Norah Crossnohere PhDDivision of General Internal Medicine
Ohio State University College of Medicine
700 Ackerman Rd
Columbus, OH 43202

Norah L Crossnohere, PhD, is a patient-centered outcomes researcher who is passionate about measuring what matters most to patients and their loved ones. Dr. Crossnohere’s research areas include advancing methods for measuring patient and caregiver preferences; engaging patients to inform medical decision-making, and; evaluating health information technologies.

Dr. Crossnohere has conducted this work in diverse clinical areas including primary care, cancer, pediatrics, and rare diseases. Her training and experience as a researcher at the intersection of social science and medicine have provided her with a robust methodological skillset, and she is experienced in the use of quantitative preference elicitation (e.g. discrete-choice experiments, best-worst scaling, health state utilities), patient-reported outcome measures (PROs), survey methods, and systematic reviews.

Dr. Crossnohere has served as principal investigator and co-investigator on internal and external grants. She is an editorial board member of The Patient-Patient-Centered Outcomes Research journal, a winner of the 2022 Outstanding Paper by a Young Investigator Award from the Society for Medical Decision Making, and a member of the Alpha Delta Omega Public Health Honors Society.

Training and Education

  • PhD, The Johns Hopkins Bloomberg School of Public Health
  • MHS, The Johns Hopkins Bloomberg School of Public Health
  • BA, Skidmore College

Select publications

Crossnohere N, Armstrong N, Fischer R, Bridges J. (2022) Understanding families experience with a diagnosis of Duchenne muscular dystrophy: A mixed-methods study. In Press at American Journal of Medical Genetics Part C.

Crossnohere N, Paskett J, Elsaid M, Bose-Brill S, Bridges J. (2022) Guidelines for artificial intelligence in medicine: A review and content analysis. In Press at Journal of Medical Internet Research.

Brundage M, Crossnohere N, O’Connell J, Rivera S, Wilson R, Wu A, Moher D, Kyte D, Reeve B, Gilbert A, Chen R, Calvert M, Snyder C for the PROTEUS Consortium. (2022). Listening to the patient voice adds value to cancer clinical trials. In Press at Journal of the National Cancer Institute.

Hollin I, Paskett J, Schuster A, Crossnohere N, Bridges J. (2022) Measuring the priorities of patients and other stakeholders in health using best-worst scaling: A systematic review. PharmacoEconomics.

Crossnohere N, Fischer R, Vroom E, Furlong P, Bridges J. (2022). A comparison of caregiver and patient preferences for treating Duchenne muscular dystrophy. The Patient—Patient-Centered Outcomes Research.

Crossnohere N, Fischer R, Lloyd A, Prosser L, Bridges J. (2021). Assessing the appropriateness of the EQ-5D for Duchenne muscular dystrophy: A patient-centered study. Medical Decision Making, 41(2) 209-221.

Crossnohere N, Weiss B, Hyman S, Bridges J. (2021) Patient preferences for health information technologies: A Systematic review. Journal of Hospital Management and Health Policy, (5) 25.

Crossnohere N, Brundage M, Calvert M, King M, Reeve B, Thorner E, Wu A, Snyder C. (2021) International guidance on selection of patient reported outcomes in clinical trials: A review. Quality of Life Research. 30(1) 21-40.

Crossnohere N, Janse S, Janssen E, Bridges J. (2021) Comparing the preferences of patients and the general public for treatment outcomes in type 2 diabetes mellitus. The Patient – Patient-Centered Outcomes Research, 14(1) 89-100.

Schoenborn N, Crossnohere N, Bridges J, Pollack C, Pilla S, Boyd C. (2019) Patient perceptions of diabetes guideline frameworks for individualizing glycemic targets. JAMA Internal Medicine, 179(12) 1642-1649.

Crossnohere N, Richardson D, Smith B, Reinhart C, O’Donoghue B, Love S, Bridges J. (2019) Side effects from acute myeloid leukemia treatment: Results from a national survey. Current Medical Research and Opinions, 35(11) 1965-1970.